* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results on May 2.
* The Burlington Massachusetts-based company is expected to
report a 10.1% increase in revenue to $43.54 million from
$39.56 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
February 23 2023, for the period ended March 31, was for revenue
between 42.60 million and 45.00 million.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $52.5, below its last closing price of $54.00.
The company's guidance on February 23 2023 for the period ended
March 31 was for Earnings before Interest and Taxes between 6
million and 7.5 million.The company's guidance on February 23
2023 for the period ended March 31 was for gross profit margin
of 64.8%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.26 0.26 0.25 Missed -3.3
Sep. 30 2022 0.27 0.28 0.25 Missed -9.9
Jun. 30 2022 0.27 0.27 0.16 Missed -39.6
Mar. 31 2022 0.28 0.28 0.27 Missed -2.6
Dec. 0.31 0.31 0.28 Missed -8.6
31 2021
Sep. 30 2021 0.33 0.33 0.30 Missed -7.7
Jun. 30 2021 0.35 0.34 0.40 Beat 18.2
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
This summary was machine generated April 29 at 01:42 GMT. All
figures in US dollars unless otherwise stated